Africa-EU after COVID-19 — let’s start with vaccines
12:35-13:25 CEST – 6 May 2021
José Manuel Barroso, Chair of the Gavi Board and President of the European Commission 2004-2014
Giorgia Giovannetti, Visiting Fellow, Robert Schuman Centre, EUI and Professor of Economics, University of Florence
Jane Kabubo-Mariara, Executive Director of the Partnership for Economic Policy and Professor of Economics, University of Nairobi
Stefano Manservisi, Special Advisor to Commissioner Paolo Gentiloni; Former Director-General for International Cooperation and Development
Vera Songwe, Executive Secretary, Economic Commission for Africa
Although Africa has managed to resist COVID-19 remarkably well, the economic consequences have been disastrous. For the first time after 25 years of continuous economic growth, Africa is facing a recession. COVID-19 has also led to increased protectionism and a delay in the implementation of the African Continental Free Trade Area Agreement. Furthermore, COVID-19 may be here to stay and could be the first of a series of “new infections” in a highly interconnected world. Considering Sub Saharan African countries’ economic structure, rapid urbanization, and often unreliable health infrastructures, and accounting for the fact that health security is a global public good, it is particularly important to have rapid and equitable access to vaccines. In many countries, health systems need to be strengthened and logistical capacity for vaccinations should be created. This panel will discuss these issues with a particular focus on policies to mitigate health, economic and social effects of the COVID-19 crisis, the global public goods nature of health security, the difficulties of planning a large-scale immunization, vaccination campaigns and prioritization and logistics.
Ethics and efficiency in vaccine distribution
12:35 – 13:25 CEST – 6 May 2021
Ellen Immergut, Head of Department of Political and Social Sciences and Chair in Political Sciences, EUI
This panel will address two key problems underpinning the ethics and efficacy of the distribution of the COVID-19 vaccine. First, the key assumptions that guide the ethics of vaccine distribution remain uncertain, such as whether the vaccines stop transmission or only prevent severe illness. Second, the most efficacious methods for distribution may conflict with both ethical guidelines and public sentiment. Ethical discussions have revolved around protecting the vulnerable, while public opinion often is based on ideas about ‘deservingness.’ But neither perspective may actually be the best guide for actually stopping the pandemic. This panel will discuss scientific findings based on simulation models of vaccine distribution, public opinion surveys, and comparative policy analysis of vaccine distribution.
How did the COVID-19 pandemic change citizens’ attitudes towards the EU, towards national governments and towards each other?
In collaboration with YouGov
15:00 – 15:30 CEST – 7 May 2021
This presentation will report on the results of the April 2021 wave of the EUI-YouGov European Solidarity Survey and compare them to previous years. Did COVID-19 enhance or erode trust in national governments? Did it boost or undermine public support for the EU and for European integration? How did it affect the willingness to share resources – money, medical equipment, intensive-care beds, or vaccines – across European borders? How did the pandemic change citizens’ perceptions of policy priorities and challenges? European averages will be explained, as well as variation across member states, social classes, and political preferences (left-right; cosmopolitan – nationalist). Areas of continuity and change will be identified and compared to 2020 and 2019.